Dawn of disease modifying interventions for dementia-Alzheimer syndrome: an assessment of safety and efficacy of promising candidates

Affiliations

• ¹ Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing 100053, China; Neurodegenerative Laboratory of Ministry of Education of the People's Republic of China, Beijing 100053, China.
• ² Department of Psychosomatic Medicine, University Medicine Rostock & Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Rostock 18147, Germany.
• ³ The Campaign to Prevent Alzheimer's Disease2020 [PAD2020.org], Potomac, MD 20854, USA.
• ⁴ Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing 100053, China; Neurodegenerative Laboratory of Ministry of Education of the People's Republic of China, Beijing 100053, China. Electronic address: [email protected].